News articles about CME Group (NASDAQ:CME) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CME Group earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 45.5741333911952 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the media stories that may have effected Accern Sentiment’s analysis:

CME Group (NASDAQ:CME) traded up 1.15% during mid-day trading on Wednesday, hitting $126.19. The stock had a trading volume of 1,416,530 shares. The firm’s 50-day moving average price is $123.56 and its 200 day moving average price is $120.67. The company has a market cap of $42.72 billion, a PE ratio of 25.76 and a beta of 0.73. CME Group has a one year low of $98.95 and a one year high of $127.96.

CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925 million for the quarter, compared to analyst estimates of $931.05 million. During the same quarter in the prior year, the company earned $1.14 EPS. CME Group’s revenue was up 2.1% on a year-over-year basis. On average, equities research analysts anticipate that CME Group will post $4.81 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s payout ratio is 53.99%.

A number of analysts recently issued reports on the company. UBS AG restated a “buy” rating and issued a $134.00 price target (down from $136.00) on shares of CME Group in a research report on Monday, June 5th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $127.00 price target on shares of CME Group in a research report on Friday, July 14th. BidaskClub downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Finally, Deutsche Bank AG decreased their target price on CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research report on Tuesday, July 4th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $131.63.

TRADEMARK VIOLATION NOTICE: This news story was published by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at

In other CME Group news, insider Kathleen M. Cronin sold 8,125 shares of the stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $127.35, for a total value of $1,034,718.75. Following the sale, the insider now owns 38,174 shares of the company’s stock, valued at approximately $4,861,458.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 10,265 shares of the stock in a transaction dated Wednesday, May 24th. The shares were sold at an average price of $117.85, for a total value of $1,209,730.25. Following the completion of the sale, the insider now directly owns 21,690 shares in the company, valued at approximately $2,556,166.50. The disclosure for this sale can be found here. In the last three months, insiders have sold 90,885 shares of company stock worth $11,217,668. 0.61% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with's FREE daily email newsletter.